GridAI Technologies (GRDX) Net Equity Issued and Repurchased (2017 - 2023)
GridAI Technologies' (GRDX) quarterly Net Equity Issued and Repurchased came in at $2.3 million in Q4 2023, up 8094.39% YoY from $28068.0 in Q4 2022, and up 27.78% on a QoQ basis from $1.8 million in Q3 2023.
GridAI Technologies (GRDX) Net Equity Issued and Repurchased (2017 - 2023) Analysis & Trends
GridAI Technologies (GRDX) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $2.3 million in Q4 2023.
- Quarterly Net Equity Issued and Repurchased rose 8094.39% year-over-year to $2.3 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $10.1 million (down 36.94% YoY) and the FY2025 annual result came in at $2.1 million, up 23.53% from the prior year.
- Net Equity Issued and Repurchased improved to $2.3 million in Q4 2023, from $1.8 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $9.1 million in Q1 2021 to a low of -$15267.0 in Q4 2019.
- A 5-year average of $3.3 million and a median of $2.2 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2019 — Net Equity Issued and Repurchased surged 3632469.11% — and 2022, when it plunged 97.31%.
- Tracing GRDX's Net Equity Issued and Repurchased over 5 years: stood at -$15267.0 in 2019, then soared by 5630.54% to $844348.0 in 2020, then gained by 23.64% to $1.0 million in 2021, then sank by 97.31% to $28068.0 in 2022, then surged by 8094.39% to $2.3 million in 2023.
- The last three Net Equity Issued and Repurchased figures came in at $2.3 million (Q4 2023), $1.8 million (Q3 2023), and $2.2 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.30 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 28,068.00 |
| Dec 31, 2022 | 28,068.00 |
| Sep 30, 2022 | 7.70 Mn |
| Sep 30, 2022 | 7.70 Mn |
| Jun 30, 2022 | 289,322.00 |
| Jun 30, 2022 | 289,322.00 |
| Mar 31, 2022 | 8.00 Mn |
| Mar 31, 2022 | 8.00 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 7.40 Mn |
| Sep 30, 2021 | 7.40 Mn |